Year |
Citation |
Score |
2024 |
Li B, Yang MY, Kim SK, Goddard WA. The G Protein-First Mechanism for Activation of the Class B Glucagon-like Peptide 1 Receptor Coupled to N-Terminal Domain-Mediated Conformational Progression. Journal of the American Chemical Society. PMID 39266057 DOI: 10.1021/jacs.4c08128 |
0.321 |
|
2024 |
Kim SK, Guthrie B, Goddard WA. Ligand-Dependent and G Protein-Dependent Properties for the Sweet Taste Heterodimer, TAS1R2/1R3. The Journal of Physical Chemistry. B. PMID 39231438 DOI: 10.1021/acs.jpcb.4c04610 |
0.303 |
|
2024 |
Kim SK, Suebka S, Gin A, Nguyen PD, Tang Y, Su J, Goddard WA. Methotrexate Inhibits the Binding of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Receptor Binding Domain to the Host-Cell Angiotensin-Converting Enzyme-2 (ACE-2) Receptor. Acs Pharmacology & Translational Science. 7: 348-362. PMID 38357278 DOI: 10.1021/acsptsci.3c00197 |
0.345 |
|
2023 |
Vo AP, Kim SK, Yang MY, Ondrus AE, Goddard WA. Fully activated structure of the sterol-bound Smoothened GPCR-Gi protein complex. Proceedings of the National Academy of Sciences of the United States of America. 120: e2300919120. PMID 38015850 DOI: 10.1073/pnas.2300919120 |
0.331 |
|
2023 |
Ko B, Jang Y, Kwak SH, You H, Kim JH, Lee JE, Park HD, Kim SK, Goddard WA, Han JH, Kim YC. Discovery of 3-Phenyl Indazole-Based Novel Chemokine-like Receptor 1 Antagonists for the Treatment of Psoriasis. Journal of Medicinal Chemistry. PMID 37883692 DOI: 10.1021/acs.jmedchem.3c01011 |
0.537 |
|
2023 |
Li B, Maruszko K, Kim SK, Yang MY, Vo AP, Goddard WA. Structure and Molecular Mechanism of Signaling for the Glucagon-like Peptide-1 Receptor Bound to Gs Protein and Exendin-P5 Biased Agonist. Journal of the American Chemical Society. PMID 37672637 DOI: 10.1021/jacs.3c05996 |
0.384 |
|
2023 |
Mafi A, Kim SK, Goddard WA. The dynamics of agonist-β-adrenergic receptor activation induced by binding of GDP-bound Gs protein. Nature Chemistry. PMID 37349378 DOI: 10.1038/s41557-023-01238-6 |
0.386 |
|
2023 |
Tokmakova A, Kim D, Guthrie B, Kim SK, Goddard WA, Liggett SB. Predicted structure and cell signaling of TAS2R14 reveal receptor hyper-flexibility for detecting diverse bitter tastes. Iscience. 26: 106422. PMID 37096045 DOI: 10.1016/j.isci.2023.106422 |
0.523 |
|
2023 |
Jung JH, Jang IH, Yang MY, Kim S, Kim SK, Goddard WA, Kim YC. Discovery and Binding Mechanism of Pyrazoloisoquinoline-Based Novel β-Arrestin Inverse Agonists of the Kappa-Opioid Receptor. Journal of Medicinal Chemistry. PMID 36987735 DOI: 10.1021/acs.jmedchem.3c00064 |
0.589 |
|
2023 |
Hernández PM, Arango CA, Kim SK, Jaramillo-Botero A, Goddard WA. Predicted Three-Dimensional Structure of the GCR1 Putative GPCR in and Its Binding to Abscisic Acid and Gibberellin A1. Journal of Agricultural and Food Chemistry. PMID 36977192 DOI: 10.1021/acs.jafc.2c06846 |
0.34 |
|
2023 |
Wang X, Neale C, Kim SK, Goddard WA, Ye L. Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery. Nature Communications. 14: 1325. PMID 36899002 DOI: 10.1038/s41467-023-36971-6 |
0.379 |
|
2022 |
Yang MY, Kim SK, Goddard WA. G protein coupling and activation of the metabotropic GABA heterodimer. Nature Communications. 13: 4612. PMID 35941188 DOI: 10.1038/s41467-022-32213-3 |
0.367 |
|
2022 |
Jacobson KA, Kim HS, Ravi G, Kim SK, Lee K, Chen A, Chen W, Kim SG, Barak D, Liang BT, Gao ZG. Engineering of A Adenosine and P2Y Nucleotide Receptors and Their Ligands. Drug Development Research. 58: 330-339. PMID 35799977 DOI: 10.1002/ddr.10168 |
0.819 |
|
2022 |
Mafi A, Kim SK, Goddard WA. The mechanism for ligand activation of the GPCR-G protein complex. Proceedings of the National Academy of Sciences of the United States of America. 119: e2110085119. PMID 35452328 DOI: 10.1073/pnas.2110085119 |
0.317 |
|
2021 |
Mafi A, Kim SK, Goddard WA. The G protein-first activation mechanism of opioid receptors by Gi protein and agonists. Qrb Discovery. 2: e9. PMID 37529677 DOI: 10.1017/qrd.2021.7 |
0.377 |
|
2021 |
Yang MY, Mafi A, Kim SK, Goddard WA, Guthrie B. Predicted structure of fully activated human bitter taste receptor TAS2R4 complexed with G protein and agonists. Qrb Discovery. 2: e3. PMID 37529671 DOI: 10.1017/qrd.2021.1 |
0.494 |
|
2021 |
Yang MY, Mafi A, Kim SK, Goddard WA, Guthrie B. Predicted structure of fully activated human bitter taste receptor TAS2R4 complexed with G protein and agonists. Qrb Discovery. 2: e3. PMID 37529671 DOI: 10.1017/qrd.2021.1 |
0.494 |
|
2021 |
Jang J, Kim SK, Guthrie B, Goddard WA. Synergic Effects in the Activation of the Sweet Receptor GPCR Heterodimer for Various Sweeteners Predicted Using Molecular Metadynamics Simulations. Journal of Agricultural and Food Chemistry. PMID 34613740 DOI: 10.1021/acs.jafc.1c03779 |
0.318 |
|
2021 |
Mafi A, Kim SK, Chou KC, Güthrie B, Goddard WA. Predicted Structure of Fully Activated Tas1R3/1R3' Homodimer Bound to G Protein and Natural Sugars: Structural Insights into G Protein Activation by a Class C Sweet Taste Homodimer with Natural Sugars. Journal of the American Chemical Society. PMID 34585929 DOI: 10.1021/jacs.1c08839 |
0.312 |
|
2021 |
Yang MY, Kim SK, Kim D, Liggett SB, Goddard WA. Structures and Agonist Binding Sites of Bitter Taste Receptor TAS2R5 Complexed with Gi Protein and Validated against Experiment. The Journal of Physical Chemistry Letters. 9293-9300. PMID 34542294 DOI: 10.1021/acs.jpclett.1c02162 |
0.519 |
|
2020 |
Mafi A, Kim SK, Goddard WA. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor. Proceedings of the National Academy of Sciences of the United States of America. PMID 32601232 DOI: 10.1073/Pnas.1918264117 |
0.408 |
|
2020 |
Mafi A, Kim SK, Goddard WA. The atomistic level structure for the activated human κ-opioid receptor bound to the full Gi protein and the MP1104 agonist. Proceedings of the National Academy of Sciences of the United States of America. PMID 32127473 DOI: 10.1073/Pnas.1910006117 |
0.477 |
|
2020 |
Sharma VK, Xuyu Y, Sanchez D, Kim S, Goddard WA, Loh YP. Extracellular interaction between Neurotrophic factor‐α1 and HTR1E serotonin receptor promotes cell survival The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.01952 |
0.44 |
|
2019 |
Jeong P, Kim SK, Li Q, Oh SJ, Son S, Chen G, Tan H, Kim S, Park JH, Park KD, Kim YO, Yoon MH, Kim YC, Goddard W. Discovery of Novel Biased Opioid Receptor Ligands through Structure-Based Pharmacophore Virtual Screening and Experiment. Chemmedchem. PMID 31359587 DOI: 10.1002/Cmdc.201900418 |
0.618 |
|
2017 |
Shankar V, Goddard WA, Kim SK, Abrol R. The Predicted 3D Structure of Human DP Prostaglandin G Protein-Coupled Receptor Bound to CPI Antagonist. Journal of Chemical Theory and Computation. PMID 29268008 DOI: 10.1021/Acs.Jctc.7B00842 |
0.568 |
|
2017 |
Kim SK, Chen Y, Abrol R, Goddard WA, Guthrie B. Activation mechanism of the G protein-coupled sweet receptor heterodimer with sweeteners and allosteric agonists. Proceedings of the National Academy of Sciences of the United States of America. PMID 28228527 DOI: 10.1073/Pnas.1700001114 |
0.565 |
|
2016 |
Kim JH, Kim SK, Lee JH, Kim YJ, Goddard WA, Kim YC. Homology modeling and molecular docking studies of Drosophila and Aedes sex peptide receptors. Journal of Molecular Graphics & Modelling. 66: 115-122. PMID 27060892 DOI: 10.1016/J.Jmgm.2016.03.014 |
0.667 |
|
2015 |
de March CA, Kim SK, Antonczak S, Goddard WA, Golebiowski J. G protein-coupled odorant receptors: From sequence to structure. Protein Science : a Publication of the Protein Society. PMID 26044705 DOI: 10.1002/Pro.2717 |
0.486 |
|
2015 |
Li Q, Kim SK, Goddard WA, Chen G, Tan H. Predicted structures for kappa opioid G-protein coupled receptor bound to selective agonists. Journal of Chemical Information and Modeling. 55: 614-27. PMID 25642595 DOI: 10.1021/Ci500523Z |
0.573 |
|
2014 |
Kim SK, Goddard WA. Predicted 3D structures of olfactory receptors with details of odorant binding to OR1G1. Journal of Computer-Aided Molecular Design. 28: 1175-90. PMID 25224127 DOI: 10.1007/S10822-014-9793-4 |
0.48 |
|
2014 |
Kim SK, Goddard WA, Yi KY, Lee BH, Lim CJ, Trzaskowski B. Predicted ligands for the human urotensin-II G protein-coupled receptor with some experimental validation. Chemmedchem. 9: 1732-43. PMID 24989481 DOI: 10.1002/Cmdc.201402087 |
0.456 |
|
2013 |
Abrol R, Kim SK, Bray JK, Trzaskowski B, Goddard WA. Conformational ensemble view of G protein-coupled receptors and the effect of mutations and ligand binding. Methods in Enzymology. 520: 31-48. PMID 23332694 DOI: 10.1016/B978-0-12-391861-1.00002-2 |
0.574 |
|
2012 |
Charlier L, Topin J, Ronin C, Kim SK, Goddard WA, Efremov R, Golebiowski J. How broadly tuned olfactory receptors equally recognize their agonists. Human OR1G1 as a test case. Cellular and Molecular Life Sciences : Cmls. 69: 4205-13. PMID 22926438 DOI: 10.1007/S00018-012-1116-0 |
0.552 |
|
2011 |
Abrol R, Kim SK, Bray JK, Griffith AR, Goddard WA. Characterizing and predicting the functional and conformational diversity of seven-transmembrane proteins. Methods (San Diego, Calif.). 55: 405-14. PMID 22197575 DOI: 10.1016/J.Ymeth.2011.12.005 |
0.52 |
|
2011 |
Kim SK, Fristrup P, Abrol R, Goddard WA. Structure-based prediction of subtype selectivity of histamine H 3 receptor selective antagonists in clinical trials Journal of Chemical Information and Modeling. 51: 3262-3274. PMID 22035233 DOI: 10.1021/Ci200435B |
0.499 |
|
2011 |
Kim SK, Riley L, Abrol R, Jacobson KA, Goddard WA. Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor. Proteins. 79: 1878-97. PMID 21488099 DOI: 10.1002/Prot.23012 |
0.663 |
|
2011 |
Kim SK, Li Y, Abrol R, Heo J, Goddard WA. Predicted structures and dynamics for agonists and antagonists bound to serotonin 5-HT2B and 5-HT2C receptors. Journal of Chemical Information and Modeling. 51: 420-33. PMID 21299232 DOI: 10.1021/Ci100375B |
0.535 |
|
2010 |
Kim SK, Li Y, Park C, Abrol R, Goddard WA. Prediction of the three-dimensional structure for the rat urotensin II receptor, and comparison of the antagonist binding sites and binding selectivity between human and rat receptors from atomistic simulations. Chemmedchem. 5: 1594-608. PMID 20683923 DOI: 10.1002/Cmdc.201000175 |
0.514 |
|
2010 |
Goddard WA, Kim SK, Li Y, Trzaskowski B, Griffith AR, Abrol R. Predicted 3D structures for adenosine receptors bound to ligands: comparison to the crystal structure. Journal of Structural Biology. 170: 10-20. PMID 20079848 DOI: 10.1016/J.Jsb.2010.01.001 |
0.489 |
|
2009 |
Gallagher DT, Smith N, Kim SK, Robinson H, Reddy PT. Profound asymmetry in the structure of the cAMP-free cAMP Receptor Protein (CRP) from Mycobacterium tuberculosis. The Journal of Biological Chemistry. 284: 8228-32. PMID 19193643 DOI: 10.1074/Jbc.C800215200 |
0.426 |
|
2008 |
Wess J, Han SJ, Kim SK, Jacobson KA, Li JH. Conformational changes involved in G-protein-coupled-receptor activation. Trends in Pharmacological Sciences. 29: 616-25. PMID 18838178 DOI: 10.1016/J.Tips.2008.08.006 |
0.648 |
|
2008 |
Melman A, Wang B, Joshi BV, Gao ZG, Castro Sd, Heller CL, Kim SK, Jeong LS, Jacobson KA. Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system. Bioorganic & Medicinal Chemistry. 16: 8546-56. PMID 18752961 DOI: 10.1016/J.Bmc.2008.08.007 |
0.815 |
|
2008 |
Li JH, Hamdan FF, Kim SK, Jacobson KA, Zhang X, Han SJ, Wess J. Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy. Biochemistry. 47: 2776-88. PMID 18247581 DOI: 10.1021/Bi7019113 |
0.681 |
|
2007 |
Li JH, Han SJ, Hamdan FF, Kim SK, Jacobson KA, Bloodworth LM, Zhang X, Wess J. Distinct structural changes in a G protein-coupled receptor caused by different classes of agonist ligands. The Journal of Biological Chemistry. 282: 26284-93. PMID 17623649 DOI: 10.1074/Jbc.M704875200 |
0.705 |
|
2007 |
Scarselli M, Li B, Kim SK, Wess J. Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation. The Journal of Biological Chemistry. 282: 7385-96. PMID 17213190 DOI: 10.1074/Jbc.M610394200 |
0.524 |
|
2007 |
Li B, Scarselli M, Knudsen CD, Kim SK, Jacobson KA, McMillin SM, Wess J. Rapid identification of functionally critical amino acids in a G protein-coupled receptor. Nature Methods. 4: 169-74. PMID 17206152 DOI: 10.1038/Nmeth990 |
0.585 |
|
2007 |
Li JH, Han S, Hamdan FF, Kim S, Jacobson KA, Bloodworth LM, Zhang X, Wess J. Identification of distinct, ligand‐specific structural changes in a G protein‐coupled receptor The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A425-C |
0.596 |
|
2006 |
Cosyn L, Palaniappan KK, Kim SK, Duong HT, Gao ZG, Jacobson KA, Van Calenbergh S. 2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists. Journal of Medicinal Chemistry. 49: 7373-83. PMID 17149867 DOI: 10.1021/Jm0608208 |
0.696 |
|
2006 |
Jacobson KA, Costanzi S, Kim SK, Roh E, Joshi BV, Tchilibon S, Duong HT, Gao ZG. Action of nucleosides and nucleotides at 7 transmembrane-spanning receptors. Nucleosides, Nucleotides & Nucleic Acids. 25: 1425-36. PMID 17067963 DOI: 10.1080/15257770600919027 |
0.842 |
|
2006 |
Kim SK, Gao ZG, Jeong LS, Jacobson KA. Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor. Journal of Molecular Graphics & Modelling. 25: 562-77. PMID 16793299 DOI: 10.1016/J.Jmgm.2006.05.004 |
0.731 |
|
2006 |
Kim SK, Jacobson KA. Computational prediction of homodimerization of the A3 adenosine receptor. Journal of Molecular Graphics & Modelling. 25: 549-61. PMID 16781879 DOI: 10.1016/J.Jmgm.2006.03.003 |
0.565 |
|
2006 |
Gao ZG, Duong HT, Sonina T, Kim SK, Van Rompaey P, Van Calenbergh S, Mamedova L, Kim HO, Kim MJ, Kim AY, Liang BT, Jeong LS, Jacobson KA. Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists. Journal of Medicinal Chemistry. 49: 2689-702. PMID 16640329 DOI: 10.1021/Jm050968B |
0.831 |
|
2006 |
Gao ZG, Joshi BV, Klutz AM, Kim SK, Lee HW, Kim HO, Jeong LS, Jacobson KA. Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety. Bioorganic & Medicinal Chemistry Letters. 16: 596-601. PMID 16289820 DOI: 10.1016/J.Bmcl.2005.10.054 |
0.662 |
|
2006 |
Gao Z, Joshi BV, Klutz AM, Kim S, Lee HW, Kim HO, Jeong LS, Jacobson KA. Conversion of A3 Adenosine Receptor Agonists into Selective Antagonists by Modification of the 5′-Ribofuran-uronamide Moiety. Cheminform. 37. DOI: 10.1002/CHIN.200618207 |
0.642 |
|
2005 |
Han SJ, Hamdan FF, Kim SK, Jacobson KA, Bloodworth LM, Li B, Wess J. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor. The Journal of Biological Chemistry. 280: 34849-58. PMID 16093246 DOI: 10.1074/Jbc.M506711200 |
0.704 |
|
2005 |
Gao ZG, Kim SK, Ijzerman AP, Jacobson KA. Allosteric modulation of the adenosine family of receptors. Mini Reviews in Medicinal Chemistry. 5: 545-53. PMID 15974932 DOI: 10.2174/1389557054023242 |
0.676 |
|
2005 |
Han SJ, Hamdan FF, Kim SK, Jacobson KA, Brichta L, Bloodworth LM, Li JH, Wess J. Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptor. The Journal of Biological Chemistry. 280: 24870-9. PMID 15870064 DOI: 10.1074/Jbc.M500379200 |
0.675 |
|
2005 |
Tchilibon S, Joshi BV, Kim SK, Duong HT, Gao ZG, Jacobson KA. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists. Journal of Medicinal Chemistry. 48: 1745-58. PMID 15771421 DOI: 10.1021/Jm049580R |
0.636 |
|
2005 |
Jacobson KA, Ohno M, Duong HT, Kim SK, Tchilibon S, Cesnek M, Holý A, Gao ZG. A neoceptor approach to unraveling microscopic interactions between the human A2A adenosine receptor and its agonists. Chemistry & Biology. 12: 237-47. PMID 15734651 DOI: 10.1016/J.Chembiol.2004.12.010 |
0.678 |
|
2005 |
Lou H, Kim SK, Zaitsev E, Snell CR, Lu B, Loh YP. Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase E Neuron. 45: 245-255. PMID 15664176 DOI: 10.1016/J.Neuron.2004.12.037 |
0.411 |
|
2005 |
Li B, Nowak NM, Kim SK, Jacobson KA, Bagheri A, Schmidt C, Wess J. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast: identification of second-site mutations that restore function to a coupling-deficient mutant M3 receptor. The Journal of Biological Chemistry. 280: 5664-75. PMID 15572356 DOI: 10.1074/Jbc.M411623200 |
0.658 |
|
2004 |
Jacobson KA, Kim SK, Costanzi S, Gao ZG. Purine receptors: GPCR structure and agonist design. Molecular Interventions. 4: 337-47. PMID 15616163 DOI: 10.1124/Mi.4.6.7 |
0.808 |
|
2004 |
Jeong LS, Kim MJ, Kim HO, Gao ZG, Kim SK, Jacobson KA, Chun MW. Design and synthesis of 3'-ureidoadenosine-5'-uronamides: effects of the 3'-ureido group on binding to the A3 adenosine receptor. Bioorganic & Medicinal Chemistry Letters. 14: 4851-4. PMID 15341938 DOI: 10.1016/J.Bmcl.2004.07.042 |
0.651 |
|
2004 |
Ohno M, Gao ZG, Van Rompaey P, Tchilibon S, Kim SK, Harris BA, Gross AS, Duong HT, Van Calenbergh S, Jacobson KA. Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position. Bioorganic & Medicinal Chemistry. 12: 2995-3007. PMID 15142558 DOI: 10.1016/J.Bmc.2004.03.031 |
0.706 |
|
2004 |
Tchilibon S, Kim SK, Gao ZG, Harris BA, Blaustein JB, Gross AS, Duong HT, Melman N, Jacobson KA. Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands. Bioorganic & Medicinal Chemistry. 12: 2021-34. PMID 15080906 DOI: 10.1016/J.Bmc.2004.02.037 |
0.687 |
|
2004 |
Jung KY, Kim SK, Gao ZG, Gross AS, Melman N, Jacobson KA, Kim YC. Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists. Bioorganic & Medicinal Chemistry. 12: 613-23. PMID 14738972 DOI: 10.1016/J.Bmc.2003.10.041 |
0.776 |
|
2003 |
Moro S, Deflorian F, Spalluto G, Pastorin G, Cacciari B, Kim SK, Jacobson KA. Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modeling. Chemical Communications (Cambridge, England). 2949-56. PMID 14703805 DOI: 10.1039/B303439A |
0.761 |
|
2003 |
Kim SK, Gao ZG, Van Rompaey P, Gross AS, Chen A, Van Calenbergh S, Jacobson KA. Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists. Journal of Medicinal Chemistry. 46: 4847-59. PMID 14584936 DOI: 10.1021/Jm0300431 |
0.662 |
|
2003 |
Lee S, Yi KY, Kim SK, Suh J, Kim NJ, Yoo SE, Lee BH, Seo HW, Kim SO, Lim H. Cardioselective anti-ischemic ATP-sensitive potassium channel (KATP) openers: benzopyranyl indoline and indole analogues. European Journal of Medicinal Chemistry. 38: 459-71. PMID 12767596 DOI: 10.1016/S0223-5234(03)00063-1 |
0.309 |
|
2003 |
Gao ZG, Kim SK, Gross AS, Chen A, Blaustein JB, Jacobson KA. Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor. Molecular Pharmacology. 63: 1021-31. PMID 12695530 DOI: 10.1124/Mol.63.5.1021 |
0.676 |
|
2003 |
Jacobson KA, Kim HS, Ravi G, Kim S, Lee K, Chen A, Chen W, Kim SG, Barak D, Liang BT, Gao Z. Engineering of A3 adenosine and P2Y nucleotide receptors and their ligands Drug Development Research. 58: 330-339. DOI: 10.1002/Ddr.10168 |
0.828 |
|
2002 |
Gao ZG, Kim SK, Biadatti T, Chen W, Lee K, Barak D, Kim SG, Johnson CR, Jacobson KA. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary. Journal of Medicinal Chemistry. 45: 4471-84. PMID 12238926 DOI: 10.1021/jm020211 |
0.818 |
|
2002 |
Gao ZG, Chen A, Barak D, Kim SK, Müller CE, Jacobson KA. Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor. The Journal of Biological Chemistry. 277: 19056-63. PMID 11891221 DOI: 10.1074/Jbc.M110960200 |
0.749 |
|
1999 |
Yoo S, Kim S, Lee S, Yi KY, Lee D. A comparative molecular field analysis and molecular modelling studies on pyridylimidazole type of angiotensin II antagonists. Bioorganic & Medicinal Chemistry. 7: 2971-2976. PMID 10658603 DOI: 10.1016/S0968-0896(99)00245-X |
0.424 |
|
1997 |
Yoo S, Lee S, Kim S, Lee S. The conformation and activity relationship of benzofuran derivatives as angiotensin II receptor antagonists Bioorganic & Medicinal Chemistry. 5: 445-459. PMID 9061209 DOI: 10.1016/S0968-0896(96)00244-1 |
0.522 |
|
Show low-probability matches. |